Related Experiment Video
Updated: Mar 26, 2026

Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts
Published on: May 25, 2018
Xanthogranulomatous pyelonephritis presenting as a pseudotumour.
Mohamed Chlif1, Marouene Chakroun1, Sami Ben Rhouma1
1Urology Department, La Rabta Hospital, Tunis, Tunisia.
Xanthogranulomatous pyelonephritis (XGPN) is a rare kidney condition often mistaken for cancer. This study highlights that conservative treatment is often appropriate, suggesting current surgical rates may be excessive.
Area of Science:
- Nephrology
- Pathology
- Urology
Background:
- Xanthogranulomatous pyelonephritis (XGPN) is an uncommon chronic kidney inflammation.
- It is often misdiagnosed due to clinical and radiological similarities to other renal conditions, particularly renal cancer.
- Focal forms of XGPN present diagnostic challenges preoperatively.
Purpose of the Study:
- To investigate the clinicopathological profile of pseudotumoral Xanthogranulomatous pyelonephritis.
- To evaluate the management strategies and outcomes for XGPN.
- To reduce misdiagnosis and unnecessary nephrectomies for XGPN.
Main Methods:
- Retrospective analysis of 12 cases of pseudotumoral XGPN.
- Review of clinical data, radiological findings, and pathological reports.
- Analysis of treatment approaches including surgery and conservative management.
Main Results:
- The average patient age was 51.52 years, with a gender ratio of 0.71.
- Obstructive renal calculi were present in 75% of patients.
- Nephrectomy was performed in 66.7% of cases, while 25% underwent partial nephrectomy; no recurrence was observed.
Conclusions:
- Pseudotumoral XGPN is a rare, benign kidney disease requiring conservative management.
- Limited awareness of XGPN contributes to a high rate of unwarranted nephrectomies.
- Clinical and pathological data should be carefully considered to optimize XGPN treatment.
More Related Videos
03:53An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas
Published on: October 10, 2025
07:10Orthotopic Xenografting of Human Luciferase-Tagged Malignant Peripheral Nerve Sheath Tumor Cells for in vivo Testing of Candidate Therapeutic Agents
Published on: March 7, 2011
Related Concept Videos
Acute Pyelonephritis I: Introduction
Acute Pyelonephritis II: Diagnostic Studies and Management
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Kidney Transplant II: Surgical Procedure